Debevoise Advises Gentiva in the Sale of Its Personal Care Operations to Addus in a Transaction Valued at Approximately $350M
June 11, 2024
June 11, 2024
NEW YORK, June 11 -- Debevoise and Plimpton, a law firm, issued the following news:
Debevoise & Plimpton LLP is advising Gentiva in the sale of its personal care operations to Addus HomeCare Corporation (NASDAQ: ADUS) in a transaction valued at approximately $350 million. For more information, please see the company's press release.
Gentiva is a family of industry-leading home healthcare providers, including hospice, palliative, home health, and personal care. Addus . . .
Debevoise & Plimpton LLP is advising Gentiva in the sale of its personal care operations to Addus HomeCare Corporation (NASDAQ: ADUS) in a transaction valued at approximately $350 million. For more information, please see the company's press release.
Gentiva is a family of industry-leading home healthcare providers, including hospice, palliative, home health, and personal care. Addus . . .